Biostructure/Bioimaging Institute, National Council for Research, Naples, Italy Diagnostic Imaging Department, Nuclear Medicine, IRCCS Fondazione G. Pascale, Naples, Italy Department of Neurogical Sciences, University Federico II, Naples, Italy Department of Diagnostic Imaging, University Federico II, Naples, Italy Ist. di Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche, Edificio 10, Via Pansini, 5, 80131 Napoli, Italy Biostructure and Bioimaging Institute, National Council for Research, Building 10, Via Pansini 5, 80131 Naples, Italy. quarante@unina. it
References Riferimenti: Adams, H.P., Koziol, J.A., Progressive cerebral atrophy in MS. a serial study using registered, volumetric MRI (2000) Neurology, 54, pp. 807-81
Alfano, B., Brunetti, A., Arpaia, M., Covelli, E.M., Ciarmiello, A., Salvatore, M., Multiparametric display of spin echo data from MR brain studies (1995) J. Magn. Reson. Imaging, 5, pp. 217-225
Alfano, B., Quarantelli, M., Brunetti, A., Larobina, M., Covelli, E.M., Tedeschi, E., Salvatore, M., Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation (1998) Magn. Reson. Med., 39, pp. 497-499
Brownell, B., Hughes, T., The distribution of plaques in the cerebrum in multiple sclerosis (1962) J. Neurol. Neurosurg. Psychiatry, 25, pp. 315-320
Chard, D.T., Griffin, C.M., Parker, G.J., Kapoor, R., Thompson, A.J., Miller, D.H., Brain atrophy in clinically early relapsing-remitting multiple sclerosis (2002) Brain, 125, pp. 327-337
Davie, C.A., Barker, G.J., Webb, S., Tofts, P.S., Thompson, A.J., Harding, A.E., McDonald, W.I., Miller, D.H., Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss (1995) Brain, 118, pp. 1583-1592
Davie, C.A., Hawkins, C.P., Barker, G.J., Brennan, A., Tofts, P.S., Miller, D.H., McDonald, W.I., Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions (1994) Brain, 117, pp. 49-58
Dawson, J.W., The histology of multiple sclerosis (1916) Trans. R. Soc. Edinburgh, 50, pp. 517-740
Ferguson, B., Matyszak, M.K., Esiri, M.M., Perry, V.H., Axonal damage in acute multiple sclerosis lesions (1997) Brain, 120, pp. 393-399
Filippi, M., Paty, D.W., Kappos, L., Barkhof, F., Compston, D.A., Thompson, A.J., Zhao, G.J., Miller, D.H., Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow-up study (1995) Neurology, 45, pp. 255-260
Ge, Y., Grossman, R.I., Udupa, J.K., Babb, J.S., Nyúl, L.G., Kolson, D.L., Brain atrophy in relapsing-remitting multiple sclerosis: Fractional volumetric analysis of gray matter and white matter (2001) Radiology, 220, pp. 606-610
Kurtzke, J.F., Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS) (1983) Neurology, 33, pp. 1444-1452
Liu, C., Edwards, S., Gong, Q., Roberts, N., Blumhardt, L.D., Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis (1999) J. Neurol. Neurosurg. Psychiatry, 66, pp. 323-330
Loizou, L.A., Rolfe, E.B., Hewazy, H., Cranial computed tomography in the diagnosis of multiple sclerosis (1982) J. Neurol. Neurosurg. Psychiatry, 45, pp. 905-912
Losseff, N.A., Wang, L., Lai, H.M., Yoo, D.S., Gawne-Cain, M.L., McDonald, W.I., Miller, D.H., Thompson, A.J., Progressive cerebral atrophy in multiple sclerosis. A serial MRI study (1996) Brain, 119, pp. 2009-2019
Lublin, F.D., Reingold, S.C., Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committeee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Neurology, 46, pp. 907-911
Miki, Y., Grossman, R.I., Udupa, J.K., Van Buchem, M.A., Wei, L., Phillips, M.D., Patel, U., Kolson, D.L., Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging (1999) Radiology, 210, pp. 769-774
Peterson, J.W., Bo, L., Mork, S., Chang, A., Trapp, B.D., Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions (2001) Ann. Neurol., 50, pp. 389-400
Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Tourtellotte, W.W., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols (1983) Ann. Neurol., 13, pp. 227-231
Rooney, W.E., Goodkin, D.E., Schuff, N., Neyerhoff, D.J., Norman, D., Weiner, M.W., 1H-MRSI of normal appearing white matter in multiple sclerosis (1997) Multiple Sclerosis, 3, pp. 231-237
Rudick, R.A., Fisher, E., Lee, J.C., Simon, J., Jacobs, L., Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS (1999) Neurology, 53, pp. 1698-1704
Simon, J.H., Jacobs, L.D., Campion, M.K., Rudick, R.A., Cookfair, D.L., Herndon, R.M., Richert, J.R., Brownscheidle, C.M., A longitudinal study of brain atrophy in relapsing multiplesclerosis (1999) Neurology, 53, pp. 139-148
Trapp, B.D., Peterson, J., Ransohof, R.M., Rudick, R., Mork, S., Bo, L., Axonal transection in the lesions of multiple sclerosis (1998) N. Engl. J. Med., 338, pp. 278-285
Vaithianathar L., Tench, C.R., Morgan, P.S., Lin, X., Blumhardt, L.D., 2002. White matter T(1) relaxation time histograms and cerebral atrophy in multiple sclerosis. J. Neurol. Sci. 15
197(12)45-50Whittall, K.P., MacKay, A.L., Li, D.K., Vavasour, I.M., Jones, C.K., Paty, D.W., Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2) (2002) Magn. Reson. Med., 47, pp. 403-408
Adams, H. P., Koziol, J. A., Progressive cerebral atrophy in MS. a serial study using registered, volumetric MRI (2000) Neurology, 54, pp. 807-81
Chard, D. T., Griffin, C. M., Parker, G. J., Kapoor, R., Thompson, A. J., Miller, D. H., Brain atrophy in clinically early relapsing-remitting multiple sclerosis (2002) Brain, 125, pp. 327-337
Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I., Miller, D. H., Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss (1995) Brain, 118, pp. 1583-1592
Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., McDonald, W. I., Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions (1994) Brain, 117, pp. 49-58
Dawson, J. W., The histology of multiple sclerosis (1916) Trans. R. Soc. Edinburgh, 50, pp. 517-740
Kurtzke, J. F., Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS) (1983) Neurology, 33, pp. 1444-1452
Loizou, L. A., Rolfe, E. B., Hewazy, H., Cranial computed tomography in the diagnosis of multiple sclerosis (1982) J. Neurol. Neurosurg. Psychiatry, 45, pp. 905-912
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., Thompson, A. J., Progressive cerebral atrophy in multiple sclerosis. A serial MRI study (1996) Brain, 119, pp. 2009-2019
Lublin, F. D., Reingold, S. C., Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committeee on Clinical Trials of New Agents in Multiple Sclerosis (1996) Neurology, 46, pp. 907-911
Peterson, J. W., Bo, L., Mork, S., Chang, A., Trapp, B. D., Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions (2001) Ann. Neurol., 50, pp. 389-400
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Tourtellotte, W. W., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols (1983) Ann. Neurol., 13, pp. 227-231
Rooney, W. E., Goodkin, D. E., Schuff, N., Neyerhoff, D. J., Norman, D., Weiner, M. W., 1H-MRSI of normal appearing white matter in multiple sclerosis (1997) Multiple Sclerosis, 3, pp. 231-237
Rudick, R. A., Fisher, E., Lee, J. C., Simon, J., Jacobs, L., Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS (1999) Neurology, 53, pp. 1698-1704
Simon, J. H., Jacobs, L. D., Campion, M. K., Rudick, R. A., Cookfair, D. L., Herndon, R. M., Richert, J. R., Brownscheidle, C. M., A longitudinal study of brain atrophy in relapsing multiplesclerosis (1999) Neurology, 53, pp. 139-148
Trapp, B. D., Peterson, J., Ransohof, R. M., Rudick, R., Mork, S., Bo, L., Axonal transection in the lesions of multiple sclerosis (1998) N. Engl. J. Med., 338, pp. 278-285
197 (12) 45-50Whittall, K. P., MacKay, A. L., Li, D. K., Vavasour, I. M., Jones, C. K., Paty, D. W., Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T (2) (2002) Magn. Reson. Med., 47, pp. 403-408
Zar, J. H., (1984) Biostatistical Analysis, , Englewood Cliffs, NJ: Prentice Hall
Brain tissue volume changes in relapsing-remitting multiple sclerosis: Correlation with lesion load
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(206 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(284 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(422 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(230 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(409 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote